PHI with Allergic rhinoconjunctivitis
How does this condition affect your private health insurance?
Rhinoconjunctivitis allergica, commonly known as hay fever or allergic rhinitis with conjunctivitis, is an inflammatory condition triggered by an immune response to airborne allergens like pollen, dust mites, or pet dander. Symptoms typically include sneezing, nasal itching, runny nose, nasal congestion, and itchy, watery, red eyes. It significantly impacts quality of life, often disrupting sleep, work, and school performance. While not life-threatening, it can lead to complications such as sinusitis or exacerbate asthma, representing a common manifestation of atopy and requiring management through avoidance, medication, or immunotherapy to alleviate discomfort and prevent secondary issues.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to several weeks, depending on allergen exposure.
Duration of Illness (Lifetime)
Chronic, recurring annually or perennially for many years.
Cost of Treatment (Initial)
Low to moderate (OTC medications, potential doctor visit).
Cost of Treatment (Lifetime)
Moderate to high, due to chronic medication, specialist visits, and potentially immunotherapy over years.
Mortality Rate
Extremely low, almost negligible.
Risk of Secondary Damages
Moderate (e.g., sinusitis, otitis media, asthma exacerbation, sleep disturbance, reduced quality of life).
Probability of Full Recovery
Low without specific interventions like immunotherapy; moderate to high with successful immunotherapy.
Underlying Disease Risk
Moderate to high (e.g., allergic asthma, atopic dermatitis, other allergic sensitivities).